Cargando…
Apixaban/dabigatran etexilate/enoxaparin sodium: Various toxicities: 8 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990636/ http://dx.doi.org/10.1007/s40278-022-12765-0 |
Ejemplares similares
-
Dabigatran-etexilate: Lack of efficacy: case report
Publicado: (2021) -
Apixaban/enoxaparin sodium: Lack of efficacy: case report
Publicado: (2021) -
Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile
por: Clemens, Andreas, et al.
Publicado: (2012) -
Dabigatran etexilate: Cholestatic liver injury: case report
Publicado: (2021) -
Enoxaparin sodium: Various toxicities: 3 case reports
Publicado: (2021)